Acoma Gliclazide Tablets

Gliclazide Tablet Uses

Gliclazide Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:

Non-Insulin Dependent Diabetes Mellitus

Gliclazide Tablet Working, Mechanism of Action and Pharmacology

Gliclazide Tablet improves the patient’s condition by performing the following functions:

• Increasing the amount of insulin released by the pancreas.
• Gliclazide Tablet – Composition and Active Ingredients
• Gliclazide Tablet is composed of the following active ingredients (salts)

Gliclazide (40 MG)

Please note that this medicine may be available in various strengths for each active ingredient listed above.

Gliclazide Tablet – Side-effects

The following is a list of possible side effects that may occur from all constituting ingredients of Gliclazide Tablet. This is not a comprehensive list. These side effects are possible, but do not always occur. Some of the side effects may be rare but serious. Consult your doctor if you observe any of the following side effects, especially if they do not go away.

• Constipation
• Jaundice Or Liver Dysfunction
• Visual Disturbances
• Indigestion
• Skin Problem
• Peeling Of Skin

Gliclazide Tablet – Precautions & How to Use

Before using this drug, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below.

• If you are suffering from severe injury, infection or undergoing major surgery
• If you have had an allergic reaction
• Swallow the whole tablet with a glass of water or non-alcoholic drink just before a meal.